PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation (Q46635617)

23 December 2017

title

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation (English)

1 reference

23 December 2017

1 reference

10

1 reference

23 December 2017

Thomas Gasser

11

Thomas Gasser

1 reference

23 December 2017

12

Ryan J Uitti

1 reference

23 December 2017

14

Zbigniew K Wszolek

1 reference

23 December 2017

13

Donald B Calne

1 reference

23 December 2017

7

Vesna Sossi

1 reference

23 December 2017

15

A Jon Stoessl

1 reference

23 December 2017

M Schulzer

3

Michael Schulzer

1 reference

23 December 2017

E Mak

4

Edwin Mak

1 reference

23 December 2017

Audrey J Strongosky

6

Audrey Strongosky

1 reference

23 December 2017

author name string

John R Adams

1

1 reference

23 December 2017

Hinke van Netten

2

1 reference

23 December 2017

Jessamyn Mckenzie

5

1 reference

23 December 2017

Thomas J Ruth

8

1 reference

23 December 2017

Chong S Lee

9

1 reference

23 December 2017

language of work or name

English

0 references

publication date

4 August 2005

1 reference

23 December 2017

published in

Brain

1 reference

23 December 2017

volume

128

1 reference

23 December 2017

issue

Pt 12

1 reference

23 December 2017

page(s)

2777-2785

1 reference

23 December 2017

Clinical features of LRRK2-associated Parkinson's disease in central Norway

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Criteria for diagnosing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Dopamine visualized in the basal ganglia of living man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

A common LRRK2 mutation in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

A large kindred with autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Familial Parkinson's disease: clinical and genetic analysis of four Basque families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Genetic clues to the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH607

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWH607

1 reference

23 December 2017

PubMed ID

16081470

1 reference

23 December 2017